Search Results

Filter
  • 1-10 of  40 results for ""Penicillanic Acid""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.

  • Authors : Seo YB; Division of Infectious Diseases, Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.; Lee J

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Escherichia coli/Escherichia coli/Escherichia coli/*drug effects ; Escherichia coli Infections/Escherichia coli Infections/Escherichia coli Infections/*drug therapy

  • Source: BMC infectious diseases [BMC Infect Dis] 2017 Jun 07; Vol. 17 (1), pp. 404. Date of Electronic Publication: 2017 Jun 07.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections.

  • Authors : Armstrong ES; Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ, 07033, USA. .; Mikulca JA

Subjects: Anti-Infective Agents, Urinary/Anti-Infective Agents, Urinary/Anti-Infective Agents, Urinary/*administration & dosage ; Cephalosporins/Cephalosporins/Cephalosporins/*administration & dosage ; Enterobacteriaceae Infections/Enterobacteriaceae Infections/Enterobacteriaceae Infections/*drug therapy

  • Source: BMC infectious diseases [BMC Infect Dis] 2016 Nov 25; Vol. 16 (1), pp. 710. Date of Electronic Publication: 2016 Nov 25.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Do piperacillin/tazobactam and other antibiotics with inhibitory activity against Clostridium difficile reduce the risk for acquisition of C. difficile colonization?

  • Authors : Kundrapu S; Department of Medicine, Infectious Diseases Division, Case Western Reserve, University School of Medicine, Cleveland, Ohio, USA.; Department of Pathology, University Hospitals Case Medical Center, Cleveland, Ohio, USA.

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Enterocolitis, Pseudomembranous/Enterocolitis, Pseudomembranous/Enterocolitis, Pseudomembranous/*drug therapy ; Penicillanic Acid/Penicillanic Acid/Penicillanic Acid/*analogs & derivatives

  • Source: BMC infectious diseases [BMC Infect Dis] 2016 Apr 18; Vol. 16, pp. 159. Date of Electronic Publication: 2016 Apr 18.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Disseminated tungiasis in a 78-year-old woman from Tanzania: a case report.

  • Authors : Pallangyo P; Unit of Research, Jakaya Kikwete Cardiac Institute, PO Box 65141, Dar es Salaam, Tanzania. .; Nicholaus P

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Ectoparasitic Infestations/Ectoparasitic Infestations/Ectoparasitic Infestations/*drug therapy ; Extremities/Extremities/Extremities/*parasitology

  • Source: Journal of medical case reports [J Med Case Rep] 2016 Dec 20; Vol. 10 (1), pp. 354. Date of Electronic Publication: 2016 Dec 20.Publisher: BioMed Central Country of Publication: England NLM ID: 101293382 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program.

  • Authors : Liu P; Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157, USA. .; Ohl C

Subjects: Penicillanic Acid/Penicillanic Acid/Penicillanic Acid/*analogs & derivatives ; Pneumonia/Pneumonia/Pneumonia/*drug therapy ; Sepsis/Sepsis/Sepsis/*drug therapy

  • Source: BMC infectious diseases [BMC Infect Dis] 2016 Dec 12; Vol. 16 (1), pp. 751. Date of Electronic Publication: 2016 Dec 12.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Complicated acute appendicitis presenting as a rapidly progressive soft tissue infection of the abdominal wall: a case report.

  • Authors : Beerle C; Department of Surgery, Clinic for Visceral and Thoracic Surgery, Kantonsspital Winterthur, Winterthur, Switzerland. .; Gelpke H

Subjects: Abdominal Wall/Abdominal Wall/Abdominal Wall/*pathology ; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Appendicitis/Appendicitis/Appendicitis/*surgery

  • Source: Journal of medical case reports [J Med Case Rep] 2016 Dec 01; Vol. 10 (1), pp. 331. Date of Electronic Publication: 2016 Dec 01.Publisher: BioMed Central Country of Publication: England NLM ID: 101293382 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Pseudomonas mendocina native valve infective endocarditis: a case report.

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Endocarditis, Bacterial/Endocarditis, Bacterial/Endocarditis, Bacterial/*diagnosis ; Heart Valve Diseases/Heart Valve Diseases/Heart Valve Diseases/*microbiology

  • Source: Journal of medical case reports [J Med Case Rep] 2016 Oct 04; Vol. 10 (1), pp. 275. Date of Electronic Publication: 2016 Oct 04.Publisher: BioMed Central Country of Publication: England NLM ID: 101293382 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Risk factors for kidney injury during vancomycin and piperacillin/tazobactam administration, including increased odds of injury with combination therapy.

  • Authors : Kim T; Grady Health System Infectious Diseases Program, Atlanta, GA, USA. .; Johns Hopkins Bayview Medical Center, Baltimore, MD, USA. .

Subjects: Acute Kidney Injury/Acute Kidney Injury/Acute Kidney Injury/*chemically induced ; Penicillanic Acid/Penicillanic Acid/Penicillanic Acid/*analogs & derivatives ; Piperacillin/Piperacillin/Piperacillin/*adverse effects

  • Source: BMC research notes [BMC Res Notes] 2015 Oct 17; Vol. 8, pp. 579. Date of Electronic Publication: 2015 Oct 17.Publisher: Biomed Central Country of Publication: England NLM ID: 101462768 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial.

  • Authors : Harris PN; University of Queensland Centre for Clinical Research, Building 71/918 Royal Brisbane & Women's Hospital Campus, Herston, 4029, Brisbane, QLD, Australia. .; Peleg AY

Subjects: Clinical Protocols*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Bacteremia/Bacteremia/Bacteremia/*drug therapy

  • Source: Trials [Trials] 2015 Jan 27; Vol. 16, pp. 24. Date of Electronic Publication: 2015 Jan 27.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium:

Record details

×
  • 1-10 of  40 results for ""Penicillanic Acid""